Articles On IDT Australia (ASX:IDT)
Title | Source | Codes | Date |
---|---|---|---|
Hot Pot Stocks: Here are 8 ASX plays that have tripled in the last 12 months
ASX pot stocks have run hot in recent months but eight in particular have been particularly rewarding for shareholders. Many pot stocks ran cold prior to COVID-19 as regulatory progress stalled and global markets didn’t take off. Australia... |
Stockhead | IDT | 3 years ago |
A glance at 2 ASX penny shares - MGC Pharmaceuticals and archTIS
Summary Australian players MGC Pharmaceuticals and ArchTIS limited were under the spotlight following recent crucial developments. Biopharma player MGC Pharma announced the acquisition of MediCaNL that is likely to deliver cost savings... |
Kalkine Media | IDT | 3 years ago |
Weed Week: 4/20 can’t help ASX cannabis companies
April 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually low. Of the 36 pot companies in the space, 27 have lost ground over the last fortnight. Just seven have advanced. Gains were led by Wide Open... |
Stockhead | IDT | 3 years ago |
Closing Bell: Today’s biggest small cap movers on the ASX
Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scr... |
Stockhead | IDT | 3 years ago |
Emyria raises AU$5 Mn to support drug registration, product portfolio expansion
Summary Emyria has received firm commitments in a well-supported placement to raise AU$5 million. The Company will use these funds to advance drug development and develop its product pipeline. The proceeds would also support the initi... |
Kalkine Media | IDT | 3 years ago |
Why are Australian healthcare shares Telix and Ramsay trending today?
Source: Have a nice day Photo, Shutterstock Summary Telix Pharmaceuticals has announced the launch of NOBLE Registry of its prostate cancer imaging agent. Global healthcare company Ramsay Health Care confirms the funding guarantee arr... |
Kalkine Media | IDT | 3 years ago |
Closing Bell: Today’s biggest small cap movers on the ASX
Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol... |
Stockhead | IDT | 3 years ago |
AstraZeneca rollout in jeopardy? The ASX’s COVID vaccine maker and wannabe seem immune
Shares in CSL (ASX:CSL) and IDT Australia (ASX:IDT) both fell early after the latest setback to Australia’s COVID vaccination program – or specifically the AstraZeneca vaccine. The Morrison government had aimed to vaccinate Australians by O... |
Stockhead | IDT | 3 years ago |
Weed Week: Australian medical cannabis prescriptions are soaring
The number of medical cannabis prescriptions issued under Australia’s special access scheme just keeps on growing. There were a record 9,959 SAS Category B marijuana prescriptions issued in March, two and a half times the number from a year... |
Stockhead | IDT | 3 years ago |
Closing Bell: Today’s biggest small cap movers on the ASX
Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t... |
Stockhead | IDT | 3 years ago |
March Winners Column: Oil is FINALLY on the boil
March got off to a rough start, with ASX small caps suffering their worst week since October and the Small Ords Index falling into the red on the year. But it got better. US punters received another stimmy cheque in the mail from President... |
Stockhead | IDT | 3 years ago |
Closing Bell: Today’s biggest small cap movers on the ASX
Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t... |
Stockhead | IDT | 3 years ago |
Weed Week: Oz cannabis revenue expected to double in 2021 as patients soar
Australia’s medical marijuana industry is showing strong growth, according to an industry-leading biannual report. The Freshleaf Analytics report, released this morning, says that patient numbers have grown 15-fold over the past two and a h... |
Stockhead | IDT | 3 years ago |
Hot Money Monday: These are the most in-demand stocks on the ASX right now
Stockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the level at which a company may have been... |
Stockhead | IDT | 3 years ago |
ScoPo’s powerplays: His Mach7 pick paid off – will Impedimed rise as well?
Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays. Themes of the week “Another s... |
Stockhead | IDT | 3 years ago |
Closing Bell: Today’s biggest small cap winners on the ASX
Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t... |
Stockhead | IDT | 3 years ago |
US cannabis market gets major boost as SAFE Act is put in front of legislators once again
The North American cannabis market received another shot in the arm this week, after legislation pertaining to the Secure and Fair Enforcement (SAFE) Banking Act was tabled in the House of Representatives once again. If passed, the SAFE Act... |
Stockhead | IDT | 3 years ago |
S&P/ASX 200 gains lustre back; CWN, NCL, QEM, TZL, ELT, ROG contribute
Source: whiteMocca, Shutterstock The S&P/ASX 200 gained substantially and closed 0.66% higher at A$6,752.50 on Monday backed by a few outperforming stocks. The ASX All Ordinaries closed at A$6,995.00, 0.51% higher. The small caps drop... |
Kalkine Media | IDT | 3 years ago |
Closing Bell: Today’s biggest small cap winners on the ASX
Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t... |
Stockhead | IDT | 3 years ago |
Why the IDT Australia (ASX:IDT) share price is up 150% in just 2 days
The IDT Australia Limited (ASX: IDT) share price was on fire again on Monday. The pharmaceutical manufacturing company’s shares were up as much as 67% to a multi-year high of 47.5 cents at one stage. When the IDT Australia share price hit... |
Motley Fool | IDT | 3 years ago |
Hot Money Monday: Oneview chalks up an RSI of 88 in the wake of investment research deal
Medtech company Oneview Health (ASX:ONE) led 25 stocks that chalked up a 14-day RSI above 70 this week, up slightly from 22 in the week prior. Stockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical... |
Stockhead | IDT | 3 years ago |
Last Orders: Small caps dip 0.5%, but finish week in the green
Small caps have closed lower today, but they finished the week in the green for a second week in a row. The Small Ordinaries index dropped 16.9 points, or 0.5 per cent, on Friday, doing slightly better than their larger peers. The ASX100 fi... |
Stockhead | IDT | 3 years ago |
IDT looks to manufacture COVID-19 vaccines on-shore
Victorian pharmaceuticals manufacturer IDT Australia (ASX: IDT) has announced it is looking into the possibility of utilising its facilities to manufacture COVID-19 vaccines. The Australian Government has requested IDT Australia undertake... |
businessnewsaustralia.com | IDT | 3 years ago |
Why COVID-19 is launching the IDT Australia (ASX:IDT) share price 65%
IDT Australia Limited (ASX: ITD) shares are soaring today after the company announced it has been approached by the Australian Government to assess the feasibility of producing COVID-19 vaccines. At the time of writing, the IDT share price... |
Motley Fool | IDT | 3 years ago |
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact
Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return... |
Stockhead | IDT | 3 years ago |
Weed Week: US pot legalisation picks up steam, and the Big Apple could be next
Pot legalisation is creeping across the US state by state, and a major market could be about to join their ranks. Reports out of New York indicate that lawmakers in the Empire State are close to signing a new bill legalising recreational ca... |
Stockhead | IDT | 3 years ago |
Here’s what IDT Australia’s (ASX:IDT) 1H FY21 numbers are conveying
Source: Shutterstock Summary IDT has posted a net profit of $1.12 million in 1H FY21. During the reported period, IDT continued to operate as an essential service throughout the Victorian lockdowns. IDT’s share price has closed flat... |
Kalkine Media | IDT | 3 years ago |
Three healthcare stocks with stellar returns in 2020
Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic. However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P... |
Kalkine Media | IDT | 3 years ago |
Pot stocks look to launch new products following yesterday’s TGA ruling
ASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re-classify low-dose cannabidiol (CBD) products. The TGA has made an interim decision to down schedule CBD products, including oil and pills,... |
Stockhead | IDT | 3 years ago |
ASX cannabis shares continue progress despite pandemic
ASX cannabis shares faded from the spotlight in 2020 as the coronavirus pandemic took over. But the Australian medical marijuana companies have been working through COVID-19 disruptions as they look to scale their businesses. Some have bee... |
Motley Fool | IDT | 3 years ago |
ASX cannabis shares adjust to coronavirus environment
Cannabis shares were considered a fad for a while. Now, they’ve proved they’re here to stay. As the Australian medicinal cannabis industry grows, ASX cannabis companies are refining their strategies. While some are focused on cultivation a... |
Motley Fool | IDT | 3 years ago |
Check up: Making it in America
Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks and of those which were trading on Tuesday, 66 were in positive territory over the last fortnight, 18 were flat and 47 saw t... |
Stockhead | IDT | 3 years ago |
Cann to supply medicinal cannabis products to EU and UK, IDT will manufacture
Australian cannabis developer Cann Group (ASX: CAN) has signed two agreements for the supply of medicinal cannabis-formulated oil and dried flower products to markets in the United Kingdom and European Union. The first deal is with UK-based... |
SmallCaps | IDT | 3 years ago |
Trading Places: This shareholder invested $150k in Predictive Discovery and made $2m
Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve keen keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f... |
Stockhead | IDT | 4 years ago |
18 Share Tips – 13 April 2020
Tom Bleakley, BW Equities BUY RECOMMENDATIONS IDT Australia (IDT) Chart: Share price over the year IDT is an Australian pharmaceutical company, with extensive experience in developing and producing high potency and high containment products... |
TheBull | IDT | 4 years ago |
This is what being on a ‘war footing’ against COVID-19 looks like
Before 1942, Australia hadn’t fully come to terms with what a world war would require it to do. By the end of 1942, after the Japanese Imperial airforce bombed Darwin, the country was a very different place. It had gone from a tiny populati... |
Stockhead | IDT | 4 years ago |
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor... |
Stockhead | IDT | 4 years ago |
How did ASX cannabis shares perform this reporting season?
Reporting season wrapped up last week with the S&P/ASX 200 Index (INDEXASX: XJO) falling more than 10% from recent highs. As fears around the spread of coronavirus escalated, the contagion of fear infected markets, prompting a major c... |
Motley Fool | IDT | 4 years ago |
Cann Group shares wilt 5% on half year operating loss
The Cann Group Ltd (ASX: CAN) share price has plunged 5.15% in early trade after the cannabis cultivator released its half year results last night. Cann Group reported a loss for the half year, but is seeking to transition to near-term pro... |
Motley Fool | IDT | 4 years ago |
Winner’s Column: A tech firm, a goldie and a cannabis company dominate January’s Top 50
Following a 30 per cent gain in 2019, the S&P/ASX Emerging Companies index – which measures overall performance of the ASX microcap sector — moved another 3 per cent higher in January. Of the sub-$400m market cap companies on our list,... |
Stockhead | IDT | 4 years ago |
Why these 3 ASX cannabis shares are flying high in 2020
ASX cannabis shares endured a tough 2019, as investors cooled on the latest investing trend. However, some of the biggest listed groups have bounced back in January and are up as much as 100% this year. Here’s why 3 of the biggest names in... |
Motley Fool | IDT | 4 years ago |
Why these ASX shares are up over 30% already in 2020
The All Ordinaries index has started 2020 in an exceptionally positive fashion. The year may be just a touch over four weeks old, but the index has already carved out a gain of 5.8%. Whilst this is impressive, a number of shares on the ind... |
Motley Fool | IDT | 4 years ago |
The ASX cannabis share hitting fresh highs in 2020
Shares in Cann Group Ltd (ASX: CAN) rose to fresh highs for the year yesterday. The Cann Group share price rose 22.55% during the day to close at $1.68, up significantly from Friday’s close of $1.36. The Cann Group share price has since f... |
Motley Fool | IDT | 4 years ago |
NT pot scripts stand at 1 as industry begs govt to act on patient access
Only one prescription for medical marijuana has been issued by a doctor in the Northern Territory, according to Minister for Health Natasha Fyles. In a submission to the Senate inquiry into barriers to patient access to marijuana, Fyles sai... |
Stockhead | IDT | 4 years ago |
10 at 10: These ASX stocks are ramping things up this morning
Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte... |
Stockhead | IDT | 4 years ago |
This ASX cannabis share is up 167% in the space of a month
The Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong gain. The medicinal cannabis company’s shares raced 13% higher to end the day at $1.07. This latest gain means that Cann Group’s shares have... |
Motley Fool | IDT | 4 years ago |
Weed Week: Cannabis munchies not a safe bake
As the world learns tasty cannabis edibles might not be the safest of munchies, Australian investors have served up 19 small cap cannabis stocks as gainers on the ASX. Cannabis edibles are legal in some US states and Canada and just one pro... |
Stockhead | IDT | 4 years ago |
Cann Group’s (ASX:CAN) extraction activities underway for medicinal cannabis resin
Cann Group (CAN) and IDT Australia (IDT) have announced that GMP extraction activities are underway for the first batches of medicinal cannabis resin The extracted resin will be used as an active pharmaceutical ingredient to produce GMP me... |
themarketherald.com.au | IDT | 4 years ago |
Cann Group and IDT Australia move closer to bringing medicinal cannabis products to market
Cann Group (ASX: CAN) and IDT Australia (ASX: IDT) are closer to producing their first medicinal cannabis products with GMP extraction activities now underway. Once extracted, the resin will be used as an active pharmaceutical ingredient fo... |
SmallCaps | IDT | 4 years ago |
Cannabis: Cann-made marijuana resin could be on the market by March
Cann Group’s (ASX: CAN) manufacturer has started making cannabis resin from the company’s plants, and it should be ready for sale by March. The resin needs to be tested for stability before being sold as oil and as an active pharmaceutical... |
Stockhead | IDT | 4 years ago |